Japan Clears First iPSC Therapies for Clinical Use  - Quiz - MDSpire

Japan Clears First iPSC Therapies for Clinical Use 

Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials

  • March 25, 2026

  • 2 min

Share

Original Source(s)

Japan Clears First iPSC Therapies for Clinical Use 

  • March 25, 2026

Related Content

Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial

AI-driven insights into protein misfolding and innate immunity in neurodegenerative diseases